Overview
Hiroaki Senju practices practicing medicine in Sasebo, Japan.
Mr. Senju is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Metastatic Pleural Tumor, and Febrile Neutropenia.
He is actively involved in clinical research, co-authoring 33 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hiroaki Senju
Is Hiroaki Senju a top-rated expert for Small Cell Lung Cancer (SCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Hiroaki Senju is classified as an Advanced expert for Small Cell Lung Cancer (SCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hiroaki Senju participate in research or clinical trials?
Yes. Hiroaki Senju has published 33 articles and abstracts on conditions like Small Cell Lung Cancer (SCLC). You can view a list of Hiroaki Senju's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung CancerMr. Senju isAdvanced. Learn about Lung Cancer.
- Small Cell Lung Cancer (SCLC)Mr. Senju isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Experienced
- AgranulocytosisMr. Senju isExperienced. Learn about Agranulocytosis.
- ChondrosarcomaMr. Senju isExperienced. Learn about Chondrosarcoma.
- EGFR Positive Lung CancerMr. Senju isExperienced. Learn about EGFR Positive Lung Cancer.
- Febrile NeutropeniaMr. Senju isExperienced. Learn about Febrile Neutropenia.
- Lung MetastasesMr. Senju isExperienced. Learn about Lung Metastases.
- Mediastinal TumorMr. Senju isExperienced. Learn about Mediastinal Tumor.
- Metastatic Pleural TumorMr. Senju isExperienced. Learn about Metastatic Pleural Tumor.
- Myoglobinuria RecurrentMr. Senju isExperienced. Learn about Myoglobinuria Recurrent.
- Necrotizing Myopathy (NM)Mr. Senju isExperienced. Learn about Necrotizing Myopathy (NM).
- Non-Small Cell Lung Cancer (NSCLC)Mr. Senju isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Pleural EffusionMr. Senju isExperienced. Learn about Pleural Effusion.
- PleurisyMr. Senju isExperienced. Learn about Pleurisy.
- PneumoniaMr. Senju isExperienced. Learn about Pneumonia.
- SilicosisMr. Senju isExperienced. Learn about Silicosis.
- Thymic Epithelial TumorMr. Senju isExperienced. Learn about Thymic Epithelial Tumor.